What is the appropriate Nystatin dosage for a pediatric patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Nystatin Dosage for Pediatric Patients

For oral candidiasis (thrush) in pediatric patients, use nystatin suspension 100,000 units/mL: infants receive 2 mL (200,000 units) four times daily, while children and adolescents receive 4-6 mL (400,000-600,000 units) four times daily for 7-14 days. 1

Age-Specific Dosing

Premature and Low Birth Weight Infants

  • 1 mL (100,000 units) four times daily is effective based on limited clinical studies 1
  • For prophylaxis against systemic fungal infection in very low birth weight (VLBW) infants: 1 mL (100,000 units) every 8 hours has been studied 2, 3

Term Infants

  • 2 mL (200,000 units) four times daily 1
  • Use dropper to place half the dose in each side of the mouth
  • Avoid feeding for 5-10 minutes after administration to maximize contact time

Children and Adolescents

  • 4-6 mL (400,000-600,000 units) four times daily 1
  • Place half the dose in each side of the mouth
  • Instruct patient to retain suspension in mouth as long as possible before swallowing

Treatment Duration and Clinical Considerations

The IDSA guidelines support nystatin as an alternative for mild oropharyngeal candidiasis, recommending either nystatin suspension (100,000 U/mL) 4-6 mL four times daily OR 1-2 nystatin pastilles (200,000 U each) four times daily for 7-14 days (strong recommendation; moderate-quality evidence) 4.

Continue treatment for at least 48 hours after symptoms resolve and cultures confirm eradication of Candida albicans 1. This is critical to prevent relapse—a common pitfall is stopping treatment too early when symptoms improve but fungal colonization persists.

Important Clinical Pearls

  • Nystatin is not absorbed systemically, making it safe but only effective for mucosal/topical candidiasis 1
  • For moderate-to-severe disease or esophageal involvement, systemic therapy with fluconazole is preferred over nystatin 4
  • The suspension should be shaken well before each use and stored at room temperature; avoid freezing 1
  • No significant adverse effects have been reported in pediatric studies, making it well-tolerated across all age groups 2, 3, 5

When NOT to Use Nystatin

Switch to systemic antifungals (fluconazole) if:

  • Moderate-to-severe oropharyngeal candidiasis
  • Esophageal candidiasis (systemic therapy always required) 4
  • Immunocompromised patients with extensive disease
  • Treatment failure after 7-14 days of appropriate nystatin therapy

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.